Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On
A30 Hayle closed LIVE: Police car in serious three-vehicle crash

A30 Hayle closed LIVE: Police car in serious three-vehicle crash

7 December 2025
Sell-out £38 Liz Earle skincare set worth £97 now back in stock in time for Christmas

Sell-out £38 Liz Earle skincare set worth £97 now back in stock in time for Christmas

7 December 2025
Lando Norris’ SPOTY chances rated against Luke Littler and Rory McIlroy after F1 title win

Lando Norris’ SPOTY chances rated against Luke Littler and Rory McIlroy after F1 title win

7 December 2025
Christmas dinner bloat helped with 63-per-day tablet called a ‘life-saver’

Christmas dinner bloat helped with 63-per-day tablet called a ‘life-saver’

7 December 2025
Emiliano Sala: Cardiff release passionate statement on eve of landmark £105m hearing

Emiliano Sala: Cardiff release passionate statement on eve of landmark £105m hearing

7 December 2025
Facebook X (Twitter) Instagram
Business Sunday, Dec 7
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » GE Vernova: I’m Loading The Truck Heading Into Q3 2025 Earnings (NYSE:GEV)
News

GE Vernova: I’m Loading The Truck Heading Into Q3 2025 Earnings (NYSE:GEV)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk20 October 20252 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
GE Vernova: I’m Loading The Truck Heading Into Q3 2025 Earnings (NYSE:GEV)
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well, you can land a Jumbo on the spread and still have clearance for take-off. From time to time, I buy shares, mostly to not be categorized as a degen by my fellow investor friends, therefore the 50%-50% allocation. My timeframe tends to be between 3-24 months.I like stocks that have experienced a recent sell-off due to non-recurrent events, particularly when insiders are buying shares at the new lower price. This is how I often screen through thousands of stocks, mainly in the US, although I may own shares in banana republics. I use fundamental analysis to check the health of companies that pass through my screening process, their leverage, and then compare their financial ratios with the sector, and industry median and average. I also do professional background checks of each insider who purchased shares after the recent sell-off. I use technical analysis to optimize the entry and exit points of my positions. I mainly use multicolor lines for support and resistance levels on weekly charts. From time to time I draw trend lines, taken for granted, in multicolor patterns. Note: I tried to keep my introduction as real, and authentic as possible. I dislike empty suits, high-level BS, deep-level BS, unnecessary jargon, and self-indulgent, third-person written introductions with an air of superiority.Thanks for reading my introduction!

Analyst’s Disclosure:I/we have a beneficial long position in the shares of GEV either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

A30 Hayle closed LIVE: Police car in serious three-vehicle crash

A30 Hayle closed LIVE: Police car in serious three-vehicle crash

Lando Norris’ SPOTY chances rated against Luke Littler and Rory McIlroy after F1 title win

Lando Norris’ SPOTY chances rated against Luke Littler and Rory McIlroy after F1 title win

Emiliano Sala: Cardiff release passionate statement on eve of landmark £105m hearing

Emiliano Sala: Cardiff release passionate statement on eve of landmark £105m hearing

Body found on M4 as motorway closed in both directions

Body found on M4 as motorway closed in both directions

Macquarie Value Fund Q3 2025 Sales And Purchases

Macquarie Value Fund Q3 2025 Sales And Purchases

UK snow forecast as Arctic weather blast days away from hitting major cities

UK snow forecast as Arctic weather blast days away from hitting major cities

Wales school to close as outbreak of vomiting illness impacts hundreds of pupils

Wales school to close as outbreak of vomiting illness impacts hundreds of pupils

Prince William to follow in Diana’s footsteps and take George to help the homeless

Prince William to follow in Diana’s footsteps and take George to help the homeless

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Editors Picks
Sell-out £38 Liz Earle skincare set worth £97 now back in stock in time for Christmas

Sell-out £38 Liz Earle skincare set worth £97 now back in stock in time for Christmas

7 December 2025
Lando Norris’ SPOTY chances rated against Luke Littler and Rory McIlroy after F1 title win

Lando Norris’ SPOTY chances rated against Luke Littler and Rory McIlroy after F1 title win

7 December 2025
Christmas dinner bloat helped with 63-per-day tablet called a ‘life-saver’

Christmas dinner bloat helped with 63-per-day tablet called a ‘life-saver’

7 December 2025
Emiliano Sala: Cardiff release passionate statement on eve of landmark £105m hearing

Emiliano Sala: Cardiff release passionate statement on eve of landmark £105m hearing

7 December 2025

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts
Concerns new DWP powers will see benefits ‘wrongly suspended’

Concerns new DWP powers will see benefits ‘wrongly suspended’

7 December 2025
Body found on M4 as motorway closed in both directions

Body found on M4 as motorway closed in both directions

7 December 2025
Martin Lewis’ MSE issues ‘last chance’ alert to all UK parents

Martin Lewis’ MSE issues ‘last chance’ alert to all UK parents

7 December 2025
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2025 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.